Immune Checkpoint Inhibitor Cardiotoxicity

365: CardioOncology: Cardiotoxicity of Novel Immunotherapies with Dr. Tomas NeilanПодробнее

Cardiotoxicity of Immune Checkpoint Inhibitors: Prof. Bernd Wintersperger -@CardioZurich 08.02.24Подробнее

Cardiac Toxicities Among Patients Treated with Immune CheckpointПодробнее

Medicine Grand Rounds: "Cardio-Oncology: A New Frontier" 1/31/2023Подробнее

Risk factors for cardiotoxic events in patients treated with immune checkpoint inhibitorsПодробнее

Cardiac Troponins and Checkpoint InhibitorsПодробнее

Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Beyond anthracyclines and trastuzumab: cardiotoxicity of novel agentsПодробнее

Immune Checkpoint Inhibitors: The Good, the Bad, and the Emerging Field of Cardio-OncologyПодробнее

January 2021 ICOS Monthly Case Study WebinarПодробнее

Cardiology MCQПодробнее

Cardiology MCQ - DiscussionПодробнее

Cardiovascular Toxicity and Immune Checkpoint InhibitorsПодробнее

How does oncology drug induce cardiotoxicity? Overview: mechanism & clinical guidelines (ESMO) 2022Подробнее

CV Impact of Immune Checkpoint Inhibitor CardiotoxicityПодробнее

Cardio-oncology: Chemotherapy-related left ventricular dysfunctionПодробнее

Cardiotoxicity from Immunotherapy: Can Advanced Cardiac Imaging Meet the Challenge?Подробнее

Cardio-Oncology: What do we know beyond anthracycline cardiotoxicity, Dr. Lili ZhangПодробнее

How should we deal with cardiotoxicity caused by immunotherapy?Подробнее